Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias.
Gojo I, Jiemjit A, Trepel JB, Sparreboom A, Figg WD, Rollins S, Tidwell ML, Greer J, Chung EJ, Lee MJ, Gore SD, Sausville EA, Zwiebel J, Karp JE.
Gojo I, et al. Among authors: tidwell ml.
Blood. 2007 Apr 1;109(7):2781-90. doi: 10.1182/blood-2006-05-021873.
Blood. 2007.
PMID: 17179232
Free PMC article.
Clinical Trial.